Medical Weight Loss for Palatine, Illinois Residents
Palatine, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Palatine through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Palatine Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Palatine, Illinois residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Palatine is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
Although our clinic is physically in Costa Mesa, California, Palatine residents receive the same physician-supervised care without leaving Illinois. We care for patients throughout downtown Palatine and the northwest Chicago suburbs of Cook County. Whether you are starting your first GLP-1 program or switching from a brand medication, your Palatine treatment plan is built around your health history and goals.
Like much of Illinois, many people in Palatine want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Palatine address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Palatine
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Palatine
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Palatine address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Palatine
How do I get treatment from Palatine?
As a Palatine, Illinois patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Palatine?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Palatine in cold-pack packaging, no lines and no drive.
How much does it cost for Palatine patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Palatine do you serve?
We serve patients from across Palatine by telehealth, including downtown Palatine and the northwest Chicago suburbs of Cook County.
How does compounded medication compare on cost for Palatine patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Palatine patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Palatine, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.